Task: Answer the multiple choice question.
Question: Which drug exhibits a 0.072% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) COc1cccc(CC2(CO)CCN(Cc3ccc(NC(C)=O)cc3)CC2)c1
b) COc1ccccc1NC(=O)C1CCN(S(=O)(=O)c2ccc3c(c2)NC(=O)C(C)S3)CC1
c) Cc1ccc(S(=O)(=O)NCC(=O)OCC(=O)Nc2ccc3c(c2)OCCO3)cc1
d) CCC(C)NC(=O)c1ccc(CN2CCc3ccccc3C2)cc1
Answer: d. CCC(C)NC(=O)c1ccc(CN2CCc3ccccc3C2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)NC(=O)c1ccc(CN2CCc3ccccc3C2)cc1
CCC(C)NC(=O)c1ccc(CN2CCc3ccccc3C2)cc1
N-butan-2-yl-4-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)benzamide